| 1 |
杨洋, 周俊, 王康恒. rTMS联合利培酮治疗阴性症状为主的老年精神分裂症的疗效及对患者认知功能和血清hs-CRP、Hcy水平的影响 [J]. 中国老年学杂志, 2023, 43(11): 2649-2652.
|
| 2 |
Chen L, Fukuda AM, Jiang S, et al. Treating depression with repetitive transcranial magnetic stimulation: A clinician's guide [J]. Am J Psychiatry, 2025, 182(6): 525-541.
|
| 3 |
Ferreira SA, Pinto N, Serrenho I, et al. Contribution of glial cells to the neuroprotective effects triggered by repetitive magnetic stimulation: a systematic review [J]. Neural Regen Res, 2024, 19(1): 116-123.
|
| 4 |
Sack A T, Paneva J, Küthe T, et al. Target engagement and brain state dependence of transcranial magnetic stimulation: implications for clinical practice [J]. Biol Psychiatry, 2024, 95(6): 536-544.
|
| 5 |
Prompiengchai S, Dunlop K. Breakthroughs and challenges for generating brain network-based biomarkers of treatment response in depression [J]. Neuropsychopharmacology, 2024, 50(1): 230-245.
|
| 6 |
Siddiqi SH, Schaper FLWV, Horn A, et al. Brain stimulation and brain lesions converge on common causal circuits in neuropsychiatric disease [J]. Nat Hum Behav, 2021, 5(12): 1707-1716.
|
| 7 |
Daksh R, Sharma P, Khanna S, et al. Modulation of neuroplasticity and neuroinflammation by exosomal proteins and microRNA in depression: A review [J]. Int J Biol Macromol, 2025, 309(Pt 2): 142829.
|
| 8 |
Liu S, Chen L, Guo M, et al. Targeted delivery of engineered RVG-BDNF-exosomes: A novel neurobiological approach for ameliorating depression and regulating neurogenesis [J]. Research (Washington D C), 2024, 7: 402.
|
| 9 |
Yu Q, Ye S, Chen M, et al. A novel function for exosomes in depression [J]. Life Sci, 2025, 369: 123558.
|
| 10 |
Wang Y, Gao C, Gao T, et al. Plasma exosomes from depression ameliorate inflammation-induced depressive-like behaviors via sigma-1 receptor delivery [J]. Brain Behav Immun, 2021, 94: 225-234.
|
| 11 |
Papakostas GI, Trivedi MH, Shelton RC, et al. Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial [J]. Mol Psychiatry, 2024, 29(8): 2287-2295.
|
| 12 |
Wu T, Yu Q, Zhu X, et al. Embracing internal states: A review of optimization of repetitive transcranial magnetic stimulation for treating depression [J]. Neurosci Bull, 2025, 41(5): 866-880.
|
| 13 |
Xian X, Cai L, Li Y, et al. Neuron secrete exosomes containing miR-9-5p to promote polarization of M1 microglia in depression [J]. J Nanobiotechnology, 2022, 20(1): 122.
|
| 14 |
Jiang S, Carpenter LL, Jiang H. Optical neuroimaging: advancing transcranial magnetic stimulation treatments of psychiatric disorders [J]. Vis Comput Ind Biomed Art, 2022, 5(1): 22.
|
| 15 |
Dalhuisen I, van Bronswijk S, Bors J, et al. The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: A meta-analysis and meta-regression of sham-controlled trials [J]. Biobehav Rev, 2022, 141: 104848.
|
| 16 |
Zhao Z, Ran X, Niu Y, et al. Predicting treatment response of repetitive transcranial magnetic stimulation in major depressive disorder using an explainable machine learning model based on electroencephalography and clinical features [J]. Biol Psychiatry Cogn Neurosci Neuroimaging, 2025, 10(6): 656-665.
|
| 17 |
Jin MX, Qin PP, Xia AWL, et al. Neurophysiological and neuroimaging markers of repetitive transcranial magnetic stimulation treatment response in major depressive disorder: A systematic review and meta-analysis of predictive modeling studies [J]. Neurosci Biobehav Rev, 2024, 162: 105695.
|
| 18 |
Han S, Li X, Wei S, et al. Orbitofrontal cortex-hippocampus potentiation mediates relief for depression: A randomized double-blind trial and TMS-EEG study [J]. Cell Rep Med, 2023, 4(6): 101060.
|
| 19 |
Madsen CA, Navarro ML, Elfving B, et al. The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood [J]. Eur Neuropsychopharmacol, 2024, 87: 35-55.
|
| 20 |
Fan C, Li Y, Lan T, et al. Microglia secrete miR-146a-5p-containing exosomes to regulate neurogenesis in depression [J]. Mol Ther, 2022, 30(3): 1300-1314.
|
| 21 |
荣婧彤, 孙思琦, 刘忠纯. 外泌体在抑郁症中研究进展 [J]. 中国神经精神疾病杂志, 2023, 49(4): 247-250.
|
| 22 |
Jannati A, Oberman LM, Rotenberg A, et al. Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation [J]. Neuropsychopharmacology, 2023, 48(1):191-208.
|
| 23 |
Zoicas I, Licht C, Mühle C, et al. Repetitive transcranial magnetic stimulation (rTMS) for depressive-like symptoms in rodent animal models [J]. Neurosci Biobehav Rev, 2024, 162: 105726.
|
| 24 |
Hu Y, Zhao M, Wang H, et al. Exosome-sheathed ROS-responsive nanogel to improve targeted therapy in perimenopausal depression [J]. J Nanobiotechnology, 2023, 21(1): 261.
|
| 25 |
Nie X, Liu Y, Yuan T, et al. Platelet-rich plasma-derived exosomes promote blood-spinal cord barrier repair and attenuate neuroinflammation after spinal cord injury [J]. J Nanobiotechnology, 2024, 22(1): 456.
|
| 26 |
Vasu SO, Kaphzan H. Calcium channels control tDCS-induced spontaneous vesicle release from axon terminals [J]. Brain Stimul, 2022, 15(1): 270-282.
|
| 27 |
Si Q, Wu L, Pang D, et al. Exosomes in brain diseases: Pathogenesis and therapeutic targets [J]. MedComm, 2023, 4(3): e287.
|
| 28 |
Cole J, Sohn MN, Harris AD, et al. Efficacy of adjunctive D-cycloserine to intermittent theta-burst stimulation for major depressive disorder: A randomized clinical trial [J]. JAMA Psychiatry, 2022, 79(12): 1153-1161.
|
| 29 |
Guo B, Zhang M, Hao W, et al. Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression [J]. Transl Psychiatry, 2023, 13(1): 5.
|
| 30 |
Wang Z, Xie Z, Zhang Z, et al. Multi-platform omics sequencing dissects the atlas of plasma-derived exosomes in rats with or without depression-like behavior after traumatic spinal cord injury [J]. Prog Neuropsychopharmacol Biol Psychiatry, 2024, 132: 110987.
|
| 31 |
Du Y, Dong J, Chen L, et al. Metabolomic identification of serum exosome-derived biomarkers for bipolar disorder [J]. Oxid Med Cell Longev, 2022, 2022: 5717445.
|
| 32 |
Saeedi S, Nagy C, Ibrahim P, et al. Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response [J]. Mol Psychiatry, 2021, 26(12): 7417-7424.
|
| 33 |
Valiuliene G, Valiulis V, Zentelyte A, et al. Anti-neuroinflammatory microRNA-146a-5p as a potential biomarker for neuronavigation-guided rTMS therapy success in medication resistant depression disorder [J]. Biomed Pharmacother, 2023, 166: 115313.
|